» Articles » PMID: 33400858

A New Clustering Method Identifies Multiple Sclerosis-specific T-cell Receptors

Overview
Specialty Neurology
Date 2021 Jan 5
PMID 33400858
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To characterize T-cell receptors (TCRs) and identify target epitopes in multiple sclerosis (MS).

Methods: Peripheral blood mononuclear cells were obtained from 39 MS patients and 19 healthy controls (HCs). TCR repertoires for α/β/δ/γ chains, TCR diversity, and V/J usage were determined by next-generation sequencing. TCR β chain repertoires were compared with affectation status using a novel clustering method, Grouping of Lymphocyte Interactions by Paratope Hotspots (GLIPH). Cytomegalovirus (CMV)-IgG was measured in an additional 113 MS patients and 93 HCs. Regulatory T cells (Tregs) were measured by flow cytometry.

Results: TCR diversity for all four chains decreased with age. TCRα and TCRβ diversity was higher in MS patients (P = 0.0015 and 0.024, respectively), even after age correction. TRAJ56 and TRBV4-3 were more prevalent in MS patients than in HCs (p  = 0.027 and 0.040, respectively). GLIPH consolidated 208,674 TCR clones from MS patients into 1,294 clusters, among which two candidate clusters were identified. The TRBV4-3 cluster was shared by HLA-DRB1*04:05-positive patients (87.5%) and predicted to recognize CMV peptides (CMV-TCR). MS Severity Score (MSSS) was lower in patients with CMV-TCR than in those without (P = 0.037). CMV-IgG-positivity was associated with lower MSSS in HLA-DRB1*04:05 carriers (P = 0.0053). HLA-DRB1*04:05-positive individuals demonstrated higher CMV-IgG titers than HLA-DRB1*04:05-negative individuals (P = 0.017). CMV-IgG-positive patients had more Tregs than CMV-IgG-negative patients (P = 0.054).

Interpretation: High TCRα/TCRβ diversity, regardless of age, is characteristic of MS. Association of a CMV-recognizing TCR with mild disability indicates CMV's protective role in HLA-DRB1*04:05-positive MS.

Citing Articles

The flow cytometric analysis of depression focusing on modern-type depression and hikikomori: Exploring the link between subtypes of depression and immunological imbalances.

Matsuo K, Watanabe M, Inamine S, Matsushima T, Kyuragi S, Maeda Y Dialogues Clin Neurosci. 2025; 27(1):13-25.

PMID: 39831784 PMC: 11748865. DOI: 10.1080/19585969.2025.2452842.


A comparison of clustering models for inference of T cell receptor antigen specificity.

Hudson D, Lubbock A, Basham M, Koohy H Immunoinformatics (Amst). 2024; 13:None.

PMID: 38525047 PMC: 10955519. DOI: 10.1016/j.immuno.2024.100033.


Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer's disease.

Hawiger D Front Aging Neurosci. 2024; 16:1350240.

PMID: 38435400 PMC: 10904586. DOI: 10.3389/fnagi.2024.1350240.


Targeted depletion of TRBV9 T cells as immunotherapy in a patient with ankylosing spondylitis.

Britanova O, Lupyr K, Staroverov D, Shagina I, Aleksandrov A, Ustyugov Y Nat Med. 2023; 29(11):2731-2736.

PMID: 37872223 PMC: 10667094. DOI: 10.1038/s41591-023-02613-z.


The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.

Li J, Xiao Z, Wang D, Jia L, Nie S, Zeng X Mol Cancer. 2023; 22(1):141.

PMID: 37649123 PMC: 10466891. DOI: 10.1186/s12943-023-01844-5.


References
1.
Kouchaki E, Salehi M, Sharif M, Nikoueinejad H, Akbari H . Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis. Iran J Basic Med Sci. 2014; 17(4):250-5. PMC: 4046232. View

2.
Britanova O, Putintseva E, Shugay M, Merzlyak E, Turchaninova M, Staroverov D . Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol. 2014; 192(6):2689-98. DOI: 10.4049/jimmunol.1302064. View

3.
Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

4.
Waubant E, Mowry E, Krupp L, Chitnis T, Yeh E, Kuntz N . Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler. 2012; 19(7):891-5. PMC: 3665694. DOI: 10.1177/1352458512469693. View

5.
Kohler S, Thiel A . Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood. 2008; 113(4):769-74. DOI: 10.1182/blood-2008-02-139154. View